Carcinoma News and Research

RSS
Carcinoma is cancer that begins in the skin or in tissues that line or cover internal organs.
Additional pathology tests can improve survival rates in patients with oesophageal cancer

Additional pathology tests can improve survival rates in patients with oesophageal cancer

European Commission approves BMY's BARACLUDE(r) to treat CHB in adult patients with liver disease

European Commission approves BMY's BARACLUDE(r) to treat CHB in adult patients with liver disease

Final data from 4SC vidofludimus ENTRANCE Phase IIa trial against IBD presented at ECCO IBD Conference

Final data from 4SC vidofludimus ENTRANCE Phase IIa trial against IBD presented at ECCO IBD Conference

Study investigates risk of dysphagia after radiotherapy treatment for head & neck cancer

Study investigates risk of dysphagia after radiotherapy treatment for head & neck cancer

The Lancet journal publishes XGEVA Phase 3 study results against prostate cancer, bone metastases

The Lancet journal publishes XGEVA Phase 3 study results against prostate cancer, bone metastases

Genentech granted FDA hearing on Avastin for metastatic breast cancer

Genentech granted FDA hearing on Avastin for metastatic breast cancer

Cannabis Science extract treatments help kill cancer cells

Cannabis Science extract treatments help kill cancer cells

Amgen announces publication of XGEVA Phase 3 study results against solid tumors in Journal of Clinical Oncology

Amgen announces publication of XGEVA Phase 3 study results against solid tumors in Journal of Clinical Oncology

Cerasome filled molecular-sized bubbles to target liver cancer cells

Cerasome filled molecular-sized bubbles to target liver cancer cells

American Journal of Clinical Oncology publishes CTI's OPAXIO phase II results against esophageal cancer

American Journal of Clinical Oncology publishes CTI's OPAXIO phase II results against esophageal cancer

Infinity commences IPI-926 Phase 2 trial in patients with pancreatic cancer

Infinity commences IPI-926 Phase 2 trial in patients with pancreatic cancer

Caution on mammograms for breast cancer survivors: Study

Caution on mammograms for breast cancer survivors: Study

Educational intervention may increase awareness about kidney transplant recipients' risk of developing skin cancer

Educational intervention may increase awareness about kidney transplant recipients' risk of developing skin cancer

John Theurer chief to present videos on new limb-sparing surgical techniques at AAOS conference

John Theurer chief to present videos on new limb-sparing surgical techniques at AAOS conference

Biocare, HJF sign license agreement to distribute antibody against prostate cancer

Biocare, HJF sign license agreement to distribute antibody against prostate cancer

Tibotec begins enrollment in TMC435 phase 3 trial for treatment of HCV

Tibotec begins enrollment in TMC435 phase 3 trial for treatment of HCV

Positive interim data from cabozantinib Phase 2 metastatic castration-resistant prostate cancer trial

Positive interim data from cabozantinib Phase 2 metastatic castration-resistant prostate cancer trial

Urocidin Phase III non-muscle-invasive bladder cancer trial interim results to be presented at EAU, AUA conferences

Urocidin Phase III non-muscle-invasive bladder cancer trial interim results to be presented at EAU, AUA conferences

Apricus Bio in discussions with FDA for PrevOnco SPA Phase III protocol

Apricus Bio in discussions with FDA for PrevOnco SPA Phase III protocol

Two researchers receive Brupbacher Prize for Cancer Research 2011

Two researchers receive Brupbacher Prize for Cancer Research 2011

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.